US Patent Issued to CARDURION PHARMACEUTICALS on Jan. 20 for "Substituted imidazo [1,2-b pyridazines and [1, 2, 4 triazolo [ 4,3-b pyridazines as camkii inhibitors" (Japanese, American Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,816, issued on Jan. 20, was assigned to CARDURION PHARMACEUTICALS INC. (Burlington, Mass.).

"Substituted imidazo [1,2-b pyridazines and [1, 2, 4 triazolo [ 4,3-b pyridazines as camkii inhibitors" was invented by Nobuyuki Matsunaga (Kanagawa, Japan), Junya Shirai (Kanagawa, Japan), Tomohiro Okawa (Kanagawa, Japan), Yasufumi Miyamoto (Kanagawa, Japan), Zenyu Shiokawa (Kanagawa, Japan), Takashi Nakahata (Kanagawa, Japan), Akito Shibuya (Kanagawa, Japan), Akira Kawada (Kanagawa, Japan) and Malcolm Maccoss (Seabrook Island, S.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a fused heteroaryl compound having a CaMKII inhib...